Benzinga | Nov 5, 2020 04:50PM EST

AcelRx Pharmaceuticals Q3 EPS $(0.10) Misses $(0.08) Estimate

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 25 percent. This is a 37.5 percent increase over losses of $(0.16) per share from the same period last year.